Protai Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$20M
- Investors
-
4
Protai Bio General Information
Description
Developer of a proteomics-centered AI-powered platform designed to improve the way new drugs are discovered. The company's platform uses mass spectrometry proteomics, other protein-oriented datasets and machine learning models to identify proteo-forms, including post-translational modifications, protein-protein interactions, and quantification that reshape the outcome of complex diseases, enabling researchers to unlock complex biological insights in drug development and improve every process while lowering costs.
Contact Information
Website
www.protai.bioCorporate Office
- Shoham 5
- Street 4
- Ramat Gan
- Israel
Corporate Office
- Shoham 5
- Street 4
- Ramat Gan
- Israel
Protai Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 15-Mar-2023 | $20M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 14-Oct-2022 | Completed | Startup |
Protai Bio Comparisons
Industry
Financing
Details
Protai Bio Competitors (9)
One of Protai Bio’s 9 competitors is Manifold Bio, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Manifold Bio | Venture Capital-Backed | Boston, MA | ||||
| LabGenius Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| ProteinQure | Venture Capital-Backed | Toronto, Canada | ||||
| BigHat Biosciences | Venture Capital-Backed | San Mateo, CA | ||||
| Ordaos | Venture Capital-Backed | New York, NY |
Protai Bio Patents
Protai Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026167419-A1 | Compounds for lysine acetyltransferase 6 (kat6) inhibition and therapeutic applications thereof | Pending | 04-Feb-2025 |
Protai Bio Signals
Protai Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Grove Ventures | Venture Capital | Minority | ||
| Maj Invest | PE/Buyout | Minority | ||
| Pitango Venture Capital | Venture Capital | Minority | ||
| Endless Frontier Labs | Accelerator/Incubator | Minority |
Protai Bio FAQs
-
When was Protai Bio founded?
Protai Bio was founded in 2021.
-
Where is Protai Bio headquartered?
Protai Bio is headquartered in Ramat Gan, Israel.
-
What is the size of Protai Bio?
Protai Bio has 28 total employees.
-
What industry is Protai Bio in?
Protai Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Protai Bio a private or public company?
Protai Bio is a Private company.
-
What is Protai Bio’s current revenue?
The current revenue for Protai Bio is .
-
How much funding has Protai Bio raised over time?
Protai Bio has raised $20M.
-
Who are Protai Bio’s investors?
Grove Ventures, Maj Invest, Pitango Venture Capital, and Endless Frontier Labs have invested in Protai Bio.
-
Who are Protai Bio’s competitors?
Manifold Bio, LabGenius Therapeutics, ProteinQure, BigHat Biosciences, and Ordaos are some of the 9 competitors of Protai Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process